Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant (opens in new tab)
Capitan Orthopedics, Inc. announced today that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacerTM implant. The post Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant appeared first on Orthopedics This Week.
Read the original article